Drug based on red wine might curb obesity and diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking SRT1720, a drug by GlaxoSmithKline unit Sirtris, did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The compound, based on red wine extract resveratrol, also extended the life of mice eating junk food by as much as 44%. Three similar drugs are undergoing clinical tests in humans.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI